Olga Vera-Lastra, Gabriela Mora, Abihai Lucas-Hernández, Alberto Ordinola-Navarro, Emmanuel Rodríguez-Chávez, Ana Lilia Peralta-Amaro, Gabriela Medina, María Pilar Cruz-Dominguez, Luis J Jara, Yehuda Shoenfeld
The vertiginous advance for identifying the genomic sequence of SARS-CoV-2 allowed the development of a vaccine including mRNA-based vaccines, inactivated viruses, protein subunits, and adenoviral vaccines such as Sputnik. This study aims to report on autoimmune disease manifestations that occurred following COVID-19 Sputnik vaccination. Patients and Methods: A retrospective study was conducted on patients with new-onset autoimmune diseases induced by a post-COVID-19 vaccine between March 2021 and December 2022, in two referral hospitals in Mexico City and Argentina...
July 4, 2023: Biomedicines